co-stimulation


Also found in: Wikipedia.

co-stimulation

Immunology The delivery of a 2nd signal from an antigen-presenting cell to a T cell, which rescues an activated T cell from anergy, allowing it to produce the lymphokines necessary for production of additional T cells
References in periodicals archive ?
Lius contributions to the field include pioneering work in the concept of T cell co-stimulation and cancer immunity, the relationship between innate and adaptive immunity and non-self-discrimination by the innate immune system.
In an early analysis of a companion study in rheumatoid arthritis, where Orencia is fully integrated into the treatment algorithm, BMS' T-cell co-stimulation modulator captures about 10% of the recently switched RA population.
Helping to advance clinical understanding of autoimmune conditions is a key focus of our immunoscience research, and were proud to introduce ORENCIA, a selective T-cell co-stimulation modulator, as an additional treatment option for PsA.
Co-stimulation blockade is associated with T-cell anergy and tolerance in animal models of autoimmune disorders indicating towards treatment free remission.
Furthermore, in vitro we investigated mRNA expression for IL-22 and IL-22 BP, and IL 22 receptor after co-stimulation of peripheral blood mononuclear cells (PBMC) from individuals with asthma and normal controls with Th2 cytokines IL-4, IL-9, and GM-CSF in a time-dependent manner.
For this purpose, it is of great importance to provide sufficient co-stimulation to the antigen presenting cells.
That's why the co-stimulation of the immune system is so important for cancer treatments.
Annotine increased mDC expression of surface molecules linked with antigen presentation and co-stimulation and increased secretion of pro-inflammatory cytokines following co-culture with allogeneic [CD4.
The NLGP also potentiates MO/M0 for better antigen presentation and simultaneous co-stimulation to effector T cells by upregulating HLA-ABC, CD80 and CD86 on [CCR5.
Bristol-Myers Squibb Company, Princeton, NJ announced the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee voted to recommend approval of belatacept, a selective co-stimulation blocker, for the prophylaxis of acute rejection in de novo kidney transplant patients.
In view of its recognized potential in the largely unmet and critical field of immune regulation, the B7/CD28 co-stimulation protein family has been an area of extensive research for a number of years.
Effect of co-stimulation on T-cell apoptosis: The PBMCs from normal subjects (n=8) were used to study the T-cell apoptosis.